Pharma Focus Asia

Repligen

LATEST NEWSRead more...

15

Jun 2024

New Kite Research Highlights Yescarta® Effectiveness in Earlier Treatment Stages for Large B-Cell Lymphoma

Kite a Gilead Company has shared new results from three studies on Yescarta for treating relapsedrefractory large Bcell lymphoma at the European Hematology Association

15

Jun 2024

Invivyd Announces VYD222's Effectiveness Against New SARS-CoV-2 KP.1.1 FLiRT and KP.3 Variants

Invivyd Inc a biopharmaceutical company focused on combating serious viral infectious diseases announced today that its investigational monoclonal antibody VYD maintains in vitro neutralization

14

Jun 2024

BeiGene and NewBridge Pharmaceuticals Conclude Partnership for BRUKINSA® (Zanubrutinib) in the MENA Region

BeiGene a global leader in oncology has decided to end its partnership with NewBridge Pharmaceuticals This decision aligns with BeiGenes strategy to increase its footprint and directly oversee

13

Jun 2024

Innovent Secures Fast Track Status from the FDA for IBI343, a Monotherapy for Advanced Pancreatic Cancer

Innovent Biologics Inc a global leader in biopharmaceuticals focuses on the development manufacturing and commercialization of highquality medicines for various major diseases including oncology

13

Jun 2024

IQVIA Introduces "One Home" Platform to Simplify Clinical Trials and Reduce Site Burden

IQVIA has introduced One Home for Sites a novel technology platform aimed at simplifying clinical trial management This platform provides a unified signon and dashboard integrating various

Solovpe

press releasesRead more...

15

Jun 2024

LIXTE Biotechnology Holdings announces collaboration on a New Colon Cancer Clinical Trial

LIXTE Biotechnology Holdings Inc a clinical stage pharmaceutical company today announced a collaboration with Roche and the Netherlands Cancer Institute

15

Jun 2024

Novavax Submits Application to U.S. FDA for Updated Protein-based 2024-2025 Formula COVID-19 Vaccine

Novavax Inc a global company advancing proteinbased vaccines with its MatrixM adjuvant today announced that it has submitted an amendment to its Emergency Use Authorization

14

Jun 2024

Ethypharm Expands Its Mesalazine (Etiasa®) Portfolio in China

Ethypharm is pleased to announce the acquisition of a suppository form of Mesalazine by its Chinese affiliate Shanghai Ethypharm Pharmaceuticals Ltd from the Chinese Company Jiangsu Anbison Pharmaceutical Leader in essential medicines for central nervous system

14

Jun 2024

Sirnaomics Demonstrates Strong Antitumor Activity of Its Novel Oligonucleotide-ChemoDrug Conjugate in Journal of Oncology Research and Therapy

Sirnaomics Ltd a leading biopharmaceutical company in discovery and development of RNAi therapeutics today announced that the Group

14

Jun 2024

SKAN Research Trust and Quadram Institute Bioscience to Develop Novel Microbial Therapies

SKAN Research Trust promoted by Indian entrepreneur Mr Ashok Soota and UKbased Quadram Institute Bioscience today announced that they will apply the cutting

14

Jun 2024

Viz.ai Collaborates with Hypertrophic Cardiomyopathy Association to Improve Care for Hypertrophic Cardiomyopathy Patients

Vizai the leader in AIpowered disease detection and intelligent care coordination today announced a collaboration with the Hypertrophic Cardiomyopathy Association the preeminent organization

18 - 19

Jun 2024

18 - 20

Jun 2024

5th RNA Editing Summit

Boston, MA, USA

18 - 19

Jun 2024

19 - 20

Jun 2024

LogiPharma Asia 2024

Equarius Hotel, Singapore

19 - 21

Jun 2024

CPHI & PMEC 2024

Shanghai, China

20 - 22

Jun 2024

20 - 22

Jun 2024
Cytiva - Supor Prime filters
MFA + MMA 2024
CPHI China || PMEC China 2024
Asia Healthcare Week 2024
CPHI Korea 2024
World Orphan Drug Congress Europe 2024

TOP ARTICLES

KNOWLEDGE BANK

  • Interviews

    Merck

    Staff Engineer, Manufacturing Science and Technology, South East Asia

    Karen Chan is a process engineer at Merck Pte Ltd Chan has six years of experience in the biopharmaceutical industry and two years of experience in research development She provides technical support in areas such as process development troubleshooting and technical training for downstream processes Chan holds a degree in Chemical Engineering from the National University of Singapore
  • Techno Trends

    VESTA - Point and Click Local Thermal Analysis

    IntroductionAnasys Instruments has launched VESTA the worlds first easy to use Local Thermal Analyzer to help pharmaceutical companies Quality Control QC of drug coatings and formulations VESTA the worlds only available thermal analysis solution for applications involving localized thermal analysis of heterogeneous samples surfaces

EDITORIAL SECTION